About: Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trial   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Teyssier Anne-Charlotte, Lapillonne Hélène, Pasquet Marlene, Ballerini Paola, Baruchel André, Ducassou Stephane, Fenneteau Odile, Petit Arnaud, Cuccuini Wendy, Ragu Christine, Preudhomme Claude, Mercher Thomas, Sirvent Nicolas, Leverger Guy. Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trial. Pediatric Hematology-Oncology, Taylor & Francis, 2017, 34 (8), pp.425--427. ⟨10.1080/08880018.2017.1414905⟩
Title
  • Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trial
dc:date
  • 2017
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software